Babcock & Wilcox Enterprises, Inc. filings document the formal disclosures of an energy technology and environmental products company serving power and industrial markets. Recent 8-K reports cover operating results, Regulation FD investor materials, material definitive agreements for natural gas-fired boiler and steam turbine systems, amendments to credit and security agreements, and dividends on the 7.75% Series A Cumulative Perpetual Preferred Stock.
Proxy and governance filings describe annual meeting proposals, board composition, director compensation policies, officer transitions, indemnification agreements, and stockholder voting matters. The filing record also identifies the company’s public securities, including common stock, preferred stock and 6.50% senior notes due 2026, alongside forward-looking disclosure tied to its project pipeline and technology portfolio.
Babcock & Wilcox Enterprises, Inc. registers 11,657,221 shares of Common Stock for resale by selling stockholders. The registration covers 1,197,221 currently outstanding shares and up to 10,460,000 shares issuable upon exercise of warrants, and the company will not receive proceeds from these resales.
The prospectus discloses 148,839,531 shares outstanding as of May 19, 2026, an NYSE listing under "BW", and a May 20, 2026 closing price of $19.17 per share. Sales may occur from time to time through brokerage or other permitted means under the plan of distribution.
Babcock & Wilcox Enterprises director Naomi Louise Boness reported compensation-related equity activity involving restricted stock units and common stock. On May 15, 2026, she exercised or converted derivative securities into 85,000 shares of common stock and received a new grant of 8,725 restricted stock units under the company’s Amended and Restated 2021 Long-Term Incentive Plan.
A portion of the vested restricted stock units representing 46,750 shares was settled in cash by the company to facilitate her tax payments, classified as a disposition to the issuer. Following these transactions, she directly owned 189,530 shares of common stock. The new restricted stock units are scheduled to vest on May 15, 2026 and May 15, 2027, or on the date of the next annual meeting in each case, whichever is earlier.
Babcock & Wilcox Enterprises, Inc. director Rebecca L. Stahl reported compensation-related equity moves. She exercised 85,000 restricted stock units into common stock and the company settled 46,750 common shares with her at $21.22 per share to facilitate tax payments. After these transactions she directly holds 184,013 common shares and 8,725 restricted stock units, with the new units vesting on May 15, 2027 or the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Alan B. Howe reported several equity compensation-related transactions in company stock. On May 15, 2026, he exercised 85,000 Restricted Stock Units, which converted into an equal number of common shares at a stated value of $21.22 per share. The filing notes that a portion of the vested restricted stock units was settled in cash by Babcock & Wilcox to facilitate his tax payments, rather than through open-market sales.
Following these transactions, Howe held 165,994 shares of common stock directly, in addition to indirect holdings of 72,606 shares through the Alan & Penny Howe Trust, where he serves as trustee, and 13,000 shares in an IRA. He also received a new grant of 8,725 Restricted Stock Units under the company’s Amended and Restated 2021 Long-Term Incentive Plan, representing a contingent right to receive common stock, with vesting tied to future dates or the next annual meeting.
Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity. On May 15, 2026, she exercised 3,021 shares of common stock at $21.22 per share from restricted stock units and held 53,021 common shares afterward.
She also received 8,725 new restricted stock units tied to common stock, which vest on May 15, 2027 or the next annual meeting, and previously received 3,021 restricted stock units that vest on May 15, 2026. After these grants, she directly holds both common shares and unvested restricted stock units.
Babcock & Wilcox Enterprises director Philip D. Moeller reported compensation-related share activity involving restricted stock units. He exercised or converted 85,000 restricted stock units into common stock, and 46,750 shares were settled in cash by the company to cover tax payments under the award terms. After these transactions, he directly held 235,809 shares of common stock. Moeller also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, which are scheduled to vest on May 15, 2027 or on the date of the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Joseph A. Tato reported compensation-related equity activity. On May 15, 2026, he exercised 85,000 restricted stock units into common stock at a reported value of $21.22 per share. To facilitate tax payments, 46,750 shares were settled back to the company in cash under the award terms, rather than sold on the open market. Following these transactions, he directly held 207,338 common shares. He also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, each representing one share of common stock, vesting by May 15, 2027 or the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises entered into an underwriting agreement for an underwritten public offering of 10,810,811 shares of common stock at $18.50 per share. Underwriters received a 30‑day option for 1,621,621 additional shares, and closing on May 18, 2026 resulted in 12,432,432 shares issued in total, for gross proceeds of approximately $200 million before fees.
All shares are being offered by the Company under its effective shelf registration statement on Form S‑3. B&W plans to use net proceeds primarily to prepay amounts under its Credit Agreement, then reborrow to fund project capital and working capital, including AI data center power generation projects, potential acquisitions, growth initiatives, balance sheet strengthening and general corporate purposes.
Babcock & Wilcox Enterprises, Inc. is offering 10,810,811 shares of Common Stock. The prospectus supplement describes a firm-commitment underwritten offering at a public offering price of $18.50 per share with gross proceeds of approximately $200.0 million and an underwriter option to purchase up to an additional 1,621,621 shares for 30 days.
The company expects to use net proceeds to prepay amounts under its Credit Agreement (subject to lender requirements), and to reborrow for project-related capital, BrightLoop commercialization, AI data center projects, potential acquisitions, and general corporate purposes. The offering will increase shares outstanding to 147,023,312 (or 148,644,933 if the option is exercised).
Babcock & Wilcox Enterprises plans an underwritten public offering of $200 million of common stock. The company expects to grant underwriters a 30-day option to buy up to an additional 15% of the shares sold. All shares will be issued by B&W under an existing shelf registration.
The company intends to use net proceeds primarily to prepay amounts outstanding under its Credit Agreement, then reborrow to fund project-related capital and working capital, including steam turbine and boiler production, AI data center power generation projects, growth initiatives, possible acquisitions, and general corporate purposes.